Hepatitis is an inflammation of the liver with concomitant damage to liver cells. The disease is most commonly attributable to viral or toxic origin.
Viral hepatitis is a highly contagious systemic infection. The virus may be carried in the saliva, semen, urine, feces, tears, and blood. The virus may be spread by intimate contact with the infected individual or via materials handled by the infected individual (such as towels, food or contaminated needles). Laboratory samples or blood products from an infected individual are also important modes of transmission. In parts of the world where hepatitis is endemic, the virus is often spread by contaminated water or milk, or by seafood from contaminated water.
Toxic hepatitis results from exposure to toxic chemicals, and is therefore not contagious.
Hepatitis may be self-limiting or chronic. The severity of the disease varies with the individual's health and the causative agent. While the majority of all forms of hepatitis completely heal, there is danger of extensive liver damage which can result in cirrhosis of the liver or death.
There is no medical treatment of viral hepatitis. Therapy is directed towards the prevention of transmission, sound nutrition, and rest to support regeneration of damaged tissue. Corticosteroids have been used in severe or chronic hepatitis, although the benefits of such therapy have not been proven. For drug or chemical hepatitis, primary aim of therapy is avoidance of the toxic agent and then sound nutrition and rest.
The primary causes of viral hepatitis are infection by the hepatitis A virus, hepatitis B virus, or any of a group of viruses known as the "non-A, non-B" viruses. These viruses have a predilection for liver cells. Viral hepatitis can also result as a complication of:
Excessive ethanol consumption
Exposure to toxic industrial chemicals
Some pharmacological agents such as:
Acetaminophen (in excess of 10 to 15 grams)
Aspirin (in excess of three grams a day)
Oral contraceptives tend to impair liver function in a small number of women, but usually do not result in tissue damage. The effects are reversible when the pill is discontinued. Women who tend to develop impaired liver function while using oral contraceptives are also susceptible to the same condition during the last trimester of pregnancy due to increased estrogen levels. Toxic hepatitis may also be idiosyncratic. In this form of chemical poisoning, an individual is unable to metabolize certain drugs or chemicals which the vast majority of people encounter without such side effects. To be considered idiosyncratic, the reaction must develop in less that 0.4% of the population exposed to that particular chemical.
Hepatitis B virus
"Non-A non-B" viral infection
Inborn errors of metabolism
In some cases the cause is unknown, although autoimmune complications has been implicated.
Signs & Symptoms
The incubation period varies with the infectious agent. Hepatitis A has an incubation period of two to six weeks. Onset of symptoms is usually acute. Hepatitis B has an incubation period of four weeks to six months. Onset of symptoms is slow, but may be more severe. The course of infection in "non-A non-B" is similar to that of hepatitis B.
Malaise Fatigue Anorexia Vomiting Joint pain Mild fever
Jaundice Enlarged liver due to inflammation Pain in the upper quadrant Hypoglycemia Dark urine Light colored stools Itching
Toxic hepatitis Onset and severity of symptoms vary greatly. Signs and symptoms of toxic hepatitis, in addition to those of viral hepatitis, may include:
Dizziness Drowsiness Rash Diarrhea Shock
Signs and symptoms of chronic hepatitis resemble those of viral hepatitis but are usually less severe.
Structure & Function: Immune System Support
Adult Child/Adolescent Beta-carotene 5 - 10 mg 2 - 5 mg Chromium 50 - 100 mcg 50 - 100 mcg Green barley* Selenium 100 - 200 mcg 50 - 150 mcg Silymarin* Vitamin A 5,000 - 10,000 IU 2,500 - 5,000 IU Vitamin C 4,000 - 6,000 mg 2,000 - 3,000 mg Vitamin E 200 - 400 IU 100 - 200 IU
* Please refer to the respective topic for specific nutrient amounts.
Note: All amounts are in addition to those supplements having a Recommended Dietary Allowance (RDA). Due to individual needs, one must always be aware of a possible undetermined effect when taking nutritional supplements. If any disturbances from the use of a particular supplement should occur, stop its use immediately and seek the care of a qualified health care professional.
The hepatitis individual should be encouraged to eat and keep fluid intake as high as possible. Several small meals should be offered in place of three large meals since the individual could experience anorexia when faced with large amounts of food.
A Low Fat Diet (Pritikin) or a Low Fat Diet (Non Pritikin) high in carbohydrate is recommended. Small amounts of fat make the meal more palatable, however excess fat can prove difficult to digest. Abstinence from alcohol is advised for as long as one year to protect the convalescing liver.
A sick liver can become unable to clear toxic amines from the system. If amines are not kept to a minimum, symptoms of brain toxicity progress and can eventually result in death. To avoid toxic accumulation of amines, a individual with hepatitis who begins to show encephalopathy is placed on a Protein Restricted Diet.
If ascites or edema is present a concomitant Mild Sodium Restriction Diet, Moderate Sodium Restriction Diet or Severe Sodium Restriction Diet is also recommended. In advanced cases, proteins are withheld entirely, and amino acids are supplied intravenously.
The diet should contain some protein to manipulate and protect whatever liver function still exists. Protein wastage of the liver and muscles can also occur with inadequate amounts protein in the diet.
1.* Hepar sulphuris calcareum - 30C
2. Bryonia alba tinct. - 15C
3. Natrum sulphuricum - 12X
Doses cited are to be administered on a 3X daily schedule, unless otherwise indicated. Dose usually continued for 2 weeks. Liquid preparations usually use 8-10 drops per dose. Solid preps are usually 3 pellets per dose. Children use 1/2 dose.
X = 1 to 10 dilution - weak (triturition)
C = 1 to 100 dilution - weak (potency)
M = 1 to 1 million dilution (very strong)
X or C underlined means it is most useful potency
Asterisk (*) = Primary remedy. Means most necessary remedy. There may be more than one remedy - if so, use all of them.
Boericke, D.E., 1988. Homeopathic Materia Medica.
Coulter, C.R., 1986. Portraits of Homeopathic Medicines.
Kent, J.T., 1989. Repertory of the Homeopathic Materia Medica.
Koehler, G., 1989. Handbook of Homeopathy.
Shingale, J.N., 1992. Bedside Prescriber.
Smith, Trevor, 1989. Homeopathic Medicine.
Ullman, Dana, 1991. The One Minute (or so) Healer.
Licorice Root (Glycyrrhiza glabra)
Milk Thistle (Silymarin)
Note: The misdirected use of an herb can produce severely adverse effects, especially in combination with prescription drugs. This Herbal information is for educational purposes and is not intended as a replacement for medical advice.
Research of the 6,000 materials used in Traditional Chinese Medicine has identified 150 which have activity against Hepatitis B virus, notably the following herbs:
Curcumin treats infectious hepatitis.
Licorice Root (Glycyrrhiza glabra) is also widely used in Japan against hepatitis B. (Shiki, 1992)
Milk Thistle is the "gold standard" in liver disease. It has both restorative and antihepatatoxic properties. Globe artichoke has similar properties.
Milk thistle enjoys major sales on the German market as a phytopharmaceutical and hepatoprotectant: over $16 million.
Schizandra has achieved 80% recovery rate among patients with chronic hepatitis. (Huang, 1993)
Rhubarb plant is used in China against viral hepatitis and has also scored a 97% cure rate for digestive diseases (e.g. bleeding and ulcers).
Blumenthal, M (Ed.): The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council. Austin, TX. 1998.
Huang, KC: The Pharmacology of Chinese Herbs. CRC, 1993.
Li, T: Rhubarb in the treatment of viral hepatitis and its mechanism of action. Chung Hsi I Chieh Ho Tsa Chih. 1985, 5:382.
Shiki, Y et al., Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody. J of Gastroenterology & Hepatology, 1992(1):12-16.
Aromatherapy - Essential Oils
Hepatitis is one aspect of liver disorders which may include congestion and deficiency, which is how the oils have been designated:
Chamomile Essence, Lemon Essence, Rosemary Essence, Thyme Essence.
Lemon Essence, Peppermint Essence, Rosemary Essence, Sage Essence, Thyme Essence.
Related Health ConditionsAbstracts
Alpers, D.H., R.E. Clouse & W.F. Stenson. 1983. Manual of Nutritional Therapeutics. Little, Brown, and Company, Boston. 457 pp.
Beeson, P.B. & Mc Dermott, W. eds. 1975. Textbook Of Medicine. 14th ed. Saunders Pub. Co., Philadelphia. 1892 pp.
Bland, Jeffrey. Medical Applications of Clinical Nutrition.: Keats, 1983.
Cabr? E & Gassull MA: Nutritional support in liver disease. Eur J Gastroenterol Hepatol, 1995 Jun, 7:6, 528-32.
Cabr? E & Gassull MA: Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance. Nutrition, 1996 Jul-Aug, 12:7-8, 542-8.
Caregaro L et al., Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr, 1996 Apr, 63:4, 602-9.
Chandra S & Mehendale HM: Nutritional modulation of the final outcome of hepatotoxic injury by energy substrates: an hypothesis for the mechanism. Med Hypotheses, 1996 Mar, 46:3, 261-8.
Chicago Dietetic Association and the South Suburban Dietetic Association of Cook and Will Counties. 1981. Manual of Clinical Dietetics. W.B. Saunders Co., Philadephia.
Corrao G et al., Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol, 1995 Dec 1, 142:11, 1136-46.
Davidson, C.S. 1978. Nutrition in Diseases of the Gastrointestinal tract: Diseases of the liver. Modern Nutrition in Health and Disease. 6th ed. R.S. Goodhart & M.E. Shils, eds. Lea & Febiger, Phila.
de la Maza MP et al., Fatty acid composition of liver total lipids in alcoholic patients with and without liver damage. Alcohol Clin Exp Res, 1996 Nov, 20:8, 1418-22.
DeMeo MT et al., Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases. Nutr Rev, 1997 Aug, 55:8, 297-302.
Eagles, J.A. & M.N. Randall. 1980. Handbook of Normal and Therapeutic Nutrition. Raven Press, New York. 323 pp.
Goldbaum, J.S. Vitamin C in the Use of Megascorbate Therapy in General Medicine. Austalas Nurses Journal, 11. 1982.
Hamilton, H.K. ed. 1982. Professional Guide To Diseases Intermed Communications Inc. Pub, Springfield, Massachusetts. 1323 pp.
Hargreaves, R.J. & K.R. Butterworth. Studies on the Effects of L-Ascorbic Acid on Hepatotoxicity. Toxicol Appl Pharmacol, 64. 1982.
Heinerman, John. 1982. Herbal Dynamics. Root of Life, Inc.: Publ.
Isselbacher, K.J. & R.D. Adams. 1980. Harrison's Principles of Internal Medicine, 9th ed. McGraw Hill Book Company Pub, N Y. 2073 pp.
Kalman DR & Saltzman JR: Nutrition status predicts survival in cirrhosis. Nutr Rev, 1996 Jul, 54:7, 217-9.
Kunz, J.R.M. 1982. The American Medical Association Family Medical Guide. Random House Pub, New York. 832 pp.
Murray, M.T., & J.E. Pizzorno. 1991. Encyclopedia of Natural Medicine. Rocklin, Ca; Prima Publishing.
Neve, J.: Physiologic and Nutritional Importance of Selenium. Experientia, 1991;47:187-193.
Nishizaki T et al., Nutritional support after hepatic resection: a randomized prospective study. Hepatogastroenterology, 1996 May-Jun, 43:9, 608-13.
Novy MA & Schwarz KB: Nutritional considerations and management of the child with liver disease. Nutrition, 1997 Mar, 13:3, 177-84.
Ola SO et al., The diagnostic utility of serum ferritin estimation in Nigerian patients with primary hepatocellular carcinoma. Nutrition, 1995 Sep-Oct, 11:5 Suppl, 532-4.
Orens, S. Hepatitis B: A Ten-Day Cure: A Personal History. Bulletin Of Philadelphia City Dental Society, 48. 1983.
Pan, W.H. et al: Vitamin A, Vitamin E or Beta-Carotene Status and Hepatitis B-Related Hepatocellular CarcinomaAmerican Journal of Epidemiology, May 1993;3(3):217-224.
Robbins, S.L. & R.S. Cotran. 1979. Pathologic Basis of Disease. 2nd ed. Saunders Pub Co., Philadelphia. 1598 pp.
Rosman AS et al., Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol, 1996 Mar, 91:3, 498-505.
Santolaria-Fern?ndez FJ et al., Nutritional assessment of drug addicts. Drug Alcohol Depend, 1995 Apr, 38:1, 11-8.
Sarin SK et al., Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease [see comments]. Am J Gastroenterol, 1997 May, 92:5, 777-83.
Wyngaarden, J.B. & L.H. Smith. 1985. Cecil's Textbook of Medicine. Saunders Pub Co., Philadelphia. 2341 pp.
- Product Categories
- Detox & Immunity
- Digestive Health
- Joint Health
- Weight Loss
- Popular Products
- CellRenew Collagen Hyaluronic Acid
- Foundation Blue-Green Algae
- Dream Health System
- Liver Cleanse
- Reference Materials
- Product Testimonials
- Health Journal Archive
- Health Briefs
- Health Basics
- Frequent Product Q&A's
- Med-Scope (health database)
- Health Conditions
- Natural Solutions
- Alternative Therapies
- Toxicity Sources
- Foods Advice
- Anatomy & Fitness